Rein TherapeuticsRNTX

13F holders, Q3 2024 (September 30)
31holders +3
5new positions
2sold out
1famous investor
$3.54avg. 13F price*

At the end of Q3 2024, 31 institutions reported holding Rein Therapeutics Inc. (RNTX) in their 13F filings, up 3 from Q2 2024. 5 opened new positions and 2 sold out. The largest holders were University of Texas/Texas Am Investment Management Co. ($5.0M), Alyeska Investment Group, L.P. ($1.9M) and Nantahala Capital Management, LLC ($1.6M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Rein Therapeutics Inc.
Filed as
AILERON THERAPEUTICS INC (Q3 2024)
CUSIP
00887A204
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 23Q1 2024Q2 2024: 28Q2 2024Q3 2024: 31Q3 2024Q4 2024: 31Q4 2024Q1 2025: 39Q1 2025Q2 2025: 36Q2 2025Q3 2025: 40Q3 2025Q4 2025: 48Q4 2025Q1 2026: 46Q1 2026Q2 2026: 59Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions5$172K
Exits2$303K

All 13F filers, Q2 2024 → Q3 2024: 339,540 shares bought and 648,953 shares sold, net −309,413 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 31 holders

University of Texas/Texas Am Investment Management Co. 0.81% Reduce -21.1% 1,403,339 $5.0M
Alyeska Investment Group, L.P. 0.01% No change 540,000 $1.9M
Nantahala Capital Management, LLC 0.14% No change 464,367 $1.6M
Vanguard Group Inc. 0.00% Reduce -14.6% 432,201 $1.5M
Cable Car Capital, LP 1.68% No change 420,000 $1.5M
Prosight Management, LP 0.33% Add +40.4% 372,157 $1.3M
Geode Capital Management, LLC 0.00% Add +34.8% 229,817 $814K
Senvest Management, LLC 0.03% No change 230,895 $801K
Sigma Planning Corp 0.02% Add +68.3% 212,410 $752K
Gagnon Securities LLC 0.05% Add +89.0% 71,761 $254K
BlackRock, Inc. 0.00% — 51,280 $182K
Texas Capital Bank Wealth Management Services Inc 0.01% No change 26,171 $93K
Northern Trust Corp. 0.00% No change 25,763 $91K
Blair William & Co. 0.00% Reduce -8.7% 25,602 $91K
NFSG Corp 0.03% New 25,000 $89K
Renaissance Technologies 0.00% Reduce -47.1% 13,164 $47K
KG Capital Management 0.01% New 13,000 $46K
State Street Corp. 0.00% No change 10,404 $37K
Warberg Asset Management LLC 0.14% Reduce -68.1% 10,000 $35K
Wells Fargo & Company 0.00% New 9,544 $34K
Royal Bank of Canada 0.00% Reduce -86.7% 8,000 $28K
Morgan Stanley 0.00% Add +344.0% 5,550 $20K
JFS Wealth Advisors, LLC 0.00% No change 1,590 $6K
US Bancorp \de 0.00% No change 1,250 $4K
Sachetta, LLC 0.00% New 1,000 $4K
Bank of America Corp. 0.00% Reduce -2.4% 285 $1K
Tower Research Capital LLC (TRC) 0.00% Reduce -93.7% 243 $860
FMR LLC 0.00% No change 233 $825
Game Plan Financial Advisors, LLC 0.00% No change 25 $89
Acadian Asset Management LLC 0.00% No change 17 $0
Avion Wealth 0.00% New 200 $0

"% of holder's portfolio" is RNTX's weight in each manager's 13F, not the share of Rein Therapeutics Inc. the manager owns.